Form Type: 4

SEC EDGAR Link
Accession Number:0001237899-19-000036
Date:2019-12-11
Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
Original Submission Date:

Reporting Person:

MURPHY ANDREW J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-12-11 A 2,625 a $0.00 47,951 direct
COMMON STOCK 2019-12-11 A 10,000 a $0.00 57,951 direct
COMMON STOCK 2019-12-11 0 $0.00 4,212 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) 372.46 2019-12-11 deemed execution date A 24,500 (a) 2029-12-11 common stock 24,500 $372.46 24,500 direct
Footnotes
IDfootnote
f1 award of restricted stock under the amended and restated 2014 long-term incentive plan that vests 50% on december 11, 2021 and 50% on december 11, 2023.
f2 award of restricted stock under the amended and restated 2014 long-term incentive plan that vests in its entirety on december 11, 2023.
f3 the stock option award vests in four equal annual installments, commencing one year after the date of grant.
WhaleWisdom Logo

Elevate your investments